One-pot synthesis of substituted pyrrole-imidazole derivatives with anticancer activity. 2020

Ming Zhang, and Yong Ding, and Hong-Xia Qin, and Zhi-Gang Xu, and Hai-Tao Lan, and Dong-Lin Yang, and Cheng Yi
Department of Abdominal Cancer, West China Hospital, West China Clinical Medical School, Sichuan University, 37 Guoxue Xiang, Chengdu, 610041, China.

A facile and efficient method to synthesize pyrrole-imidazole was developed via a post-Ugi cascade reaction followed by one purification procedure. Synthesized pyrrole-imidazole was collected by performing a mild reaction and a simple procedure, which could be applicable to a broad scope of functionalized anilines. The screening results demonstrated that compound 7e exhibited a high potency of anticancer activity in human pancreatic cancer cell lines PANC and ASPC-1. Our work shed light on the potential of post-Ugi cascade reaction in combinatorial and medicinal chemistry.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D011758 Pyrroles Azoles of one NITROGEN and two double bonds that have aromatic chemical properties. Pyrrole
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

Ming Zhang, and Yong Ding, and Hong-Xia Qin, and Zhi-Gang Xu, and Hai-Tao Lan, and Dong-Lin Yang, and Cheng Yi
February 2017, Chemistry & biodiversity,
Ming Zhang, and Yong Ding, and Hong-Xia Qin, and Zhi-Gang Xu, and Hai-Tao Lan, and Dong-Lin Yang, and Cheng Yi
February 2005, The Journal of organic chemistry,
Ming Zhang, and Yong Ding, and Hong-Xia Qin, and Zhi-Gang Xu, and Hai-Tao Lan, and Dong-Lin Yang, and Cheng Yi
February 2017, Bioorganic & medicinal chemistry,
Ming Zhang, and Yong Ding, and Hong-Xia Qin, and Zhi-Gang Xu, and Hai-Tao Lan, and Dong-Lin Yang, and Cheng Yi
March 2012, Bioorganic & medicinal chemistry letters,
Ming Zhang, and Yong Ding, and Hong-Xia Qin, and Zhi-Gang Xu, and Hai-Tao Lan, and Dong-Lin Yang, and Cheng Yi
February 2011, Molecular diversity,
Ming Zhang, and Yong Ding, and Hong-Xia Qin, and Zhi-Gang Xu, and Hai-Tao Lan, and Dong-Lin Yang, and Cheng Yi
March 2019, Organic & biomolecular chemistry,
Ming Zhang, and Yong Ding, and Hong-Xia Qin, and Zhi-Gang Xu, and Hai-Tao Lan, and Dong-Lin Yang, and Cheng Yi
March 2015, European journal of organic chemistry,
Ming Zhang, and Yong Ding, and Hong-Xia Qin, and Zhi-Gang Xu, and Hai-Tao Lan, and Dong-Lin Yang, and Cheng Yi
May 2023, RSC advances,
Ming Zhang, and Yong Ding, and Hong-Xia Qin, and Zhi-Gang Xu, and Hai-Tao Lan, and Dong-Lin Yang, and Cheng Yi
August 1980, Chemical & pharmaceutical bulletin,
Ming Zhang, and Yong Ding, and Hong-Xia Qin, and Zhi-Gang Xu, and Hai-Tao Lan, and Dong-Lin Yang, and Cheng Yi
December 1995, Arzneimittel-Forschung,
Copied contents to your clipboard!